186 related articles for article (PubMed ID: 29940232)
21. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy.
Kaufmann S; Russo GI; Bamberg F; Löwe L; Morgia G; Nikolaou K; Stenzl A; Kruck S; Bedke J
World J Urol; 2018 May; 36(5):761-768. PubMed ID: 29380130
[TBL] [Abstract][Full Text] [Related]
23. The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy.
Günzel K; Cash H; Buckendahl J; Königbauer M; Asbach P; Haas M; Neymeyer J; Hinz S; Miller K; Kempkensteffen C
BMC Urol; 2017 Jan; 17(1):7. PubMed ID: 28086856
[TBL] [Abstract][Full Text] [Related]
24. The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.
Ma TM; Tosoian JJ; Schaeffer EM; Landis P; Wolf S; Macura KJ; Epstein JI; Mamawala M; Carter HB
Eur Urol; 2017 Feb; 71(2):174-180. PubMed ID: 27236496
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer.
Hakozaki Y; Matsushima H; Kumagai J; Murata T; Masuda T; Hirai Y; Oda M; Kawauchi N; Yokoyama M; Homma Y
BMC Urol; 2017 Dec; 17(1):117. PubMed ID: 29233150
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Role of Magnetic Resonance Imaging-Targeted Biopsy for Prostate Cancer in Biopsy-Naïve Men: A Meta-Analysis.
Tu X; Liu Z; Zhang C; Chang T; Xu H; Bao Y; Li J; Jin K; Yuan Q; Qiu S; Yang L; Wei Q
Urol Int; 2020; 104(3-4):187-198. PubMed ID: 31825927
[TBL] [Abstract][Full Text] [Related]
27. Comparison of classical transrectal prostate biopsy versus cognitive registration in rebiopsy.
Barbas Bernardos G; Herranz Amo F; de Miguel Campos E; Luis Cardo A; Herranz Arriero A; Cancho Gil MJ; Caño Velasco J; Jara Rascón J; Mayor de Castro J; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):228-233. PubMed ID: 30833102
[TBL] [Abstract][Full Text] [Related]
28. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?
Liu H; Ruan M; Wang H; Wang H; Li X; Song G
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):589-595. PubMed ID: 32719353
[TBL] [Abstract][Full Text] [Related]
29. The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy.
Chang CH; Chiu HC; Lin WC; Ho TL; Chang H; Chang YH; Huang CP; Wu HC; Yang CR; Hsieh PF
Biomed Res Int; 2017; 2017():7617148. PubMed ID: 29159180
[TBL] [Abstract][Full Text] [Related]
30. Strain Elastography-Targeted Biopsy: Does Prostate Volume Affect Prostate Cancer Detection?
Zhu YC; Shan J; Zhang Y; Jiang Q; Wang YB; Deng SH; Qu QH; Li Q
Med Sci Monit; 2019 Nov; 25():8836-8842. PubMed ID: 31754091
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
32. Dynamic evaluation of MRI-targeted, systematic and combined biopsy for prostate cancer diagnosis through 10 years of practice in a single institution.
Lenfant L; Renard-Penna R; de Rycke Y; Rouprêt M; Beaugerie A; Comperat E; Chartier-Kastler E; Mozer PC
World J Urol; 2022 Jul; 40(7):1661-1668. PubMed ID: 35482073
[TBL] [Abstract][Full Text] [Related]
33. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.
Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
World J Urol; 2020 Mar; 38(3):663-671. PubMed ID: 31197523
[TBL] [Abstract][Full Text] [Related]
34. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients.
Yunkai Z; Yaqing C; Jun J; Tingyue Q; Weiyong L; Yuehong Q; Wenbin G; Lifeng W; Jun Q
World J Urol; 2019 May; 37(5):805-811. PubMed ID: 30187133
[TBL] [Abstract][Full Text] [Related]
35. Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
Ploussard G; Borgmann H; Briganti A; de Visschere P; Fütterer JJ; Gandaglia G; Heidegger I; Kretschmer A; Mathieu R; Ost P; Sooriakumaran P; Surcel C; Tilki D; Tsaur I; Valerio M; van den Bergh R;
World J Urol; 2019 Feb; 37(2):243-251. PubMed ID: 29967944
[TBL] [Abstract][Full Text] [Related]
36. Systematic biopsy should not be omitted in the era of combined magnetic resonance imaging/ultrasound fusion-guided biopsies of the prostate.
Lodeta B; Trkulja V; Kolroser-Sarmiento G; Jozipovic D; Salmhofer A; Augustin H
Int Urol Nephrol; 2021 Nov; 53(11):2251-2259. PubMed ID: 34505227
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer diagnosis: Efficacy of a simple electromagnetic MRI-TRUS fusion method to target biopsies.
Jelidi A; Ohana M; Labani A; Alemann G; Lang H; Roy C
Eur J Radiol; 2017 Jan; 86():127-134. PubMed ID: 28027738
[TBL] [Abstract][Full Text] [Related]
38. Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.
Mendhiratta N; Meng X; Rosenkrantz AB; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
Urology; 2015 Dec; 86(6):1192-8. PubMed ID: 26335497
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
[TBL] [Abstract][Full Text] [Related]
40. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
Distler F; Radtke JP; Kesch C; Roethke M; Schlemmer HP; Roth W; Hohenfellner M; Hadaschik B
Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
